{"database": "press", "table": "releases", "rows": [["https://chrissmith.house.gov/news/documentsingle.aspx?DocumentID=415899", "TAPinto article on Smith's remarks on Alzheimer's'Rep. Chris Smith Highlights Alzheimer's Research Advances, Calls for Greater Support for Patients and Caregivers'", "2026-10-23", "2026", "2026-10", "Republican", "House", "NJ", "Christopher H. Smith", "S000522", "chrissmith.house.gov", "chrissmith", "https://chrissmith.house.gov/news/documentquery.aspx", "scraper", "By Jeanne Wall\n\nPublished October 23, 2026 at 12:48 AM\n\nNEW JERSEY \u2014 As millions of Americans live with Alzheimer\u2019s disease and families shoulder the growing demands of caregiving, U.S. Rep. Chris Smith is highlighting advances in research, the importance of early detection and the need for continued federal investment in treatment and support.\n\nSmith (R-N.J.), founder and co-chair of the bipartisan Congressional Alzheimer\u2019s Caucus, delivered remarks Oct. 22 at the U.S. Department of Health and Human Services\u2019 first-ever Alzheimer\u2019s Disease and Related Dementias Summit. The gathering brought attention to ongoing research, care challenges and efforts to improve the lives of people affected by Alzheimer\u2019s and related dementias.\n\n\u201cSpecial thanks to Secretary Kennedy for his amazing efforts to combat Alzheimer\u2019s Disease and for hosting the first-ever Alzheimer\u2019s Disease and Related Dementias Summit,\u201d Smith said.\n\nHe also thanked the summit\u2019s panelists for helping bring renewed attention to the disease and efforts to alleviate its symptoms and ultimately find a cure.\n\nSmith has been involved in Alzheimer\u2019s advocacy for more than two decades. In 1999, he and Sen. Ed Markey established the bipartisan Congressional Alzheimer\u2019s Caucus, which Smith continues to co-chair. He also sponsored the Ronald Reagan Alzheimer\u2019s Breakthrough Act, which proposed doubling National Institutes of Health funding for Alzheimer\u2019s research to $1.4 billion annually.\n\nA significant legislative milestone followed in 2011, when Congress passed the National Alzheimer\u2019s Project Act, which Smith co-authored. The law established a national strategy to address Alzheimer\u2019s disease and created an advisory committee to coordinate a federal response.\n\nAccording to Smith, federal Alzheimer\u2019s research funding through the NIH has grown from $600 million in 2015 to more than $3.8 billion in fiscal year 2026, an increase of more than 600%.\n\n\u201cThis funding has yielded real, tangible advancements in our understanding of Alzheimer\u2019s and other dementias,\u201d Smith said.\n\nHe pointed to a new NIH-funded biomarker test developed earlier this year that can distinguish between stages of Alzheimer\u2019s disease, describing the research as an important advance in identifying the disease earlier and helping mitigate cognitive decline.\n\nUnderstanding Alzheimer\u2019s disease and the need for early detection\n\nAlzheimer\u2019s disease is a progressive brain disorder that damages memory and thinking skills and eventually interferes with a person\u2019s ability to carry out everyday activities. It is the most common cause of dementia, an umbrella term for conditions that affect memory, reasoning and other cognitive abilities.\n\nAlthough Alzheimer\u2019s is more common among older adults, it is not a normal part of aging. Researchers continue to investigate its causes, how it progresses and how treatments may help people maintain cognitive function for longer.\n\nEarly detection is an increasingly important part of that effort. While there is currently no cure, some treatments can slow the progression of Alzheimer\u2019s in certain people during the early stages of the disease. An earlier diagnosis can also help patients and families discuss treatment options, plan for future care and access support services.\n\nResearch into biomarkers \u2014 measurable biological signs of disease \u2014 is expanding the tools available to researchers and clinicians. Some blood-based tests can help identify biological changes associated with Alzheimer\u2019s, while newer research is exploring ways to assess disease stages and predict progression. These advances may improve diagnosis and treatment planning, although testing must be interpreted in the context of a person's symptoms and clinical evaluation.\n\nThe scale of the disease underscores the urgency. According to the Alzheimer\u2019s Association\u2019s 2026 Facts and Figures report, an estimated 7.4 million Americans age 65 and older are living with Alzheimer\u2019s dementia. Without medical breakthroughs to prevent or cure the disease, that number could rise to approximately 13.8 million by 2060.\n\nNew Jersey is also significantly affected. The Alzheimer\u2019s Association estimates that 185,000 state residents age 65 and older are living with Alzheimer\u2019s disease, with hundreds of thousands of family caregivers providing essential support to people with dementia.\n\nDespite advances in research and growing awareness, many people with dementia remain undiagnosed or unaware of their diagnosis. In his summit remarks, Smith cited an estimate that 58% of older adults in the United States with probable dementia are either undiagnosed or unaware of their diagnosis.\n\nCaregivers face mounting demands\n\nBeyond the effects on patients, Alzheimer\u2019s disease places substantial emotional, physical and financial demands on families. Caregivers often help with daily activities, medical appointments, medications and household needs as the disease progresses, frequently while balancing jobs and responsibilities to other family members.\n\nSmith cited estimates that more than 12 million family members and other unpaid caregivers provided approximately 19.6 billion hours of care to people living with Alzheimer\u2019s or other dementias in 2025.\n\n\u201cWe can and should do more to ease the financial, physical, and mental burdens these caregivers face,\u201d Smith said.\n\nThe Alzheimer\u2019s Association\u2019s national data similarly illustrate the magnitude of that responsibility. Its 2026 report estimates that unpaid dementia caregiving reached an economic value of more than $446 billion in 2025, reflecting the extensive work performed by family members and friends outside the paid health care system.\n\nAccess to reliable information, caregiver education, respite services and community support can help families navigate the challenges of caring for a loved one with dementia. Such services are especially important as the number of people living with Alzheimer\u2019s is expected to grow.\n\nContinued federal focus\n\nSmith welcomed the announcement of a new National Plan at the summit and emphasized the importance of continued engagement with advocates and caregivers.\n\nHe credited organizations such as the Alzheimer\u2019s Association and individuals who share their personal experiences with helping advance research funding and support for affected families. Among those he recognized was his friend Christine Hopkins.\n\nSmith said he hopes the summit\u2019s discussions will offer further insight into the experiences of people living with Alzheimer\u2019s and identify ways for the federal government to advance innovation, improve care and support, and strengthen prevention efforts.\n\nThe broader challenge, he said, remains finding better ways to address the disease while working toward a cure.\n\nIn his closing remarks, Smith expressed hope for continued progress in research and treatment, ending with the aspiration that, \u201cone day, God willing, a cure\u201d will be found.\n\nThis article was published on October 23, 2026 and can be found online at:", 1, "2026-10-24T09:19:38Z", "2026-10-24T09:20:16Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://chrissmith.house.gov/news/documentsingle.aspx?DocumentID=415899"], "units": {}, "query_ms": 0.7539619691669941, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}